Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations
What Are the Projections for Medical Device Clinical Trials Market Size and CAGR During 2025-2029?
The medical device clinical trials market size has grown strongly in recent years. It will grow from $16.87 billion in 2024 to $18.07 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing demand for innovative medical technologies, regulatory support for clinical research, growing aging population, expansion of healthcare infrastructure, and increase in investment from public and private sectors.
The medical device clinical trials market size is expected to see strong growth in the next few years. It will grow to $23.75 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for personalized medical devices, rising focus on real-world evidence, growing use of AI in trial design and monitoring, expansion of decentralized and virtual trials, regulatory support for faster approvals, and increasing investments in digital health innovations. Major trends in the forecast period include adoption of decentralized trials, integration of AI and big data analytics, use of wearable monitoring devices, enhanced regulatory harmonization, and advancements in trial design and data analytics.
Claim your free report sample now:
What Are the Key Market Drivers and Opportunities in the Medical Device Clinical Trials Market?
The rising prevalence of chronic diseases are expected to propel the growth of the medical device clinical trials market going forward. Chronic diseases are long-term health conditions that progress slowly and require ongoing medical management. Chronic diseases are growing due to sedentary lifestyles where people spend long hours sitting at desks or using electronic devices, which reduces calorie expenditure and weakens cardiovascular health, leading to conditions such as obesity, diabetes, and hypertension. The rise in chronic diseases drives the need for medical device clinical trials to develop and validate innovative devices for effective diagnosis, treatment, and management. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the medical device clinical trials market.
What Are the Key Segments in the Medical Device Clinical Trials Market?
The medical device clinical trials market covered in this report is segmented –
1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
3) By Study Design: Interventional, Observational, Expanded Access
Subsegments:
1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies, Manufacturing Process Validation
4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies
What Are the Key Trends Shaping the Medical Device Clinical Trials Market?
Major companies operating in the medical device clinical trials market are focusing on developing AI-powered medical device software to optimize clinical trial protocols and resource allocation to enhance trial efficiency and reduce costs. AI-powered medical device software refers to software used in healthcare that leverages artificial intelligence (AI) algorithms—especially machine learning or deep learning, to support or automate medical tasks. For instance, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI, an AI-based software designed to accelerate and optimize clinical trials for medical devices. Protocol AI leverages Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically drafting clinical trial protocols in minutes. This innovation significantly reduces the time and cost required for protocol development, which traditionally takes about six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.
Who Are the Top Competitors in the Medical Device Clinical Trials Market?
Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG
Get the full medical device clinical trials market report here:
Which Regions Offer the Highest Potential for Medical Device Clinical Trials Market Expansion?
North America was the largest region in the medical device clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment